financetom
Business
financetom
/
Business
/
Embraer focused on selling current products, no plans for sizeable capex cycle
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Embraer focused on selling current products, no plans for sizeable capex cycle
May 1, 2024 5:08 AM

PARIS, May 1 (Reuters) - Brazilian planemaker Embraer ( ERJ )

is focused on selling its current portfolio of

recently developed products, a company spokesperson told

Reuters, adding there was no big capital expenditures (capex)

cycle in the works.

He was reacting to an earlier Wall Street Journal article

saying Embraer ( ERJ ) was exploring options for a new narrowbody jet

model to challenge the market dominance of Boeing ( BA ) and

Airbus.

"Embraer ( ERJ ) certainly has the capability to develop a new

narrow body aircraft. However, we have a young and very

successful portfolio of products developed in recent years, and

we are really focused on selling those products and making

Embraer ( ERJ ) bigger and stronger," the spokesperson.

"We don't have any plan for a sizable cycle of capex at this

time," he added

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Arkansas-based Evolve Bank confirms cyber attack and data breach
Arkansas-based Evolve Bank confirms cyber attack and data breach
Jun 27, 2024
(Reuters) - Evolve Bank and Trust confirmed on Wednesday it was the victim of a cybersecurity incident that involved customers' data being illegally released on the dark web. A spokesperson for the Arkansas-based lender said they have engaged appropriate law enforcement agencies to aid in their investigation and response efforts. We will offer all impacted customers (end users) complimentary credit...
Gain Therapeutics Names Gene Mack as Interim Chief Executive Officer
Gain Therapeutics Names Gene Mack as Interim Chief Executive Officer
Jun 27, 2024
05:38 PM EDT, 06/27/2024 (MT Newswires) -- Gain Therapeutics ( GANX ) said late Thursday that it appointed Gene Mack, its chief financial officer, as interim chief executive officer, effective June 25. Mack will retain his role as the CFO. The company said the move followed the departure of its chief executive, Matthias Alder, to pursue other opportunities. Meanwhile, Khalid...
Microsoft tells clients Russian hackers viewed emails, Bloomberg News reports
Microsoft tells clients Russian hackers viewed emails, Bloomberg News reports
Jun 27, 2024
June 27 (Reuters) - Microsoft Corp ( MSFT ) is informing some of its customers that their emails were accessed by a Russian state-sponsored hacking group that breached the technology giant's internal systems, Bloomberg News reported, citing a company spokesperson. The company did not immediately respond to a Reuters request for comment. ...
BRIEF-Lanesborough REIT Announces That Resolution To Approve The Sale Of  All Of Its Properties Not Passed By Unitholders
BRIEF-Lanesborough REIT Announces That Resolution To Approve The Sale Of All Of Its Properties Not Passed By Unitholders
Jun 27, 2024
Lanesborough Real Estate Investment Trust: * LANESBOROUGH REIT ANNOUNCES THAT RESOLUTION TO APPROVE THE SALE OF ALL OF ITS PROPERTIES NOT PASSED BY UNITHOLDERS Source text for Eikon: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved